全文获取类型
收费全文 | 1823篇 |
免费 | 149篇 |
国内免费 | 21篇 |
专业分类
耳鼻咽喉 | 4篇 |
儿科学 | 157篇 |
妇产科学 | 109篇 |
基础医学 | 179篇 |
口腔科学 | 70篇 |
临床医学 | 169篇 |
内科学 | 364篇 |
皮肤病学 | 77篇 |
神经病学 | 73篇 |
特种医学 | 145篇 |
外科学 | 188篇 |
综合类 | 51篇 |
预防医学 | 110篇 |
眼科学 | 41篇 |
药学 | 113篇 |
中国医学 | 18篇 |
肿瘤学 | 125篇 |
出版年
2023年 | 26篇 |
2022年 | 13篇 |
2021年 | 40篇 |
2020年 | 37篇 |
2019年 | 48篇 |
2018年 | 54篇 |
2017年 | 50篇 |
2016年 | 39篇 |
2015年 | 54篇 |
2014年 | 80篇 |
2013年 | 120篇 |
2012年 | 104篇 |
2011年 | 78篇 |
2010年 | 95篇 |
2009年 | 76篇 |
2008年 | 80篇 |
2007年 | 79篇 |
2006年 | 111篇 |
2005年 | 89篇 |
2004年 | 76篇 |
2003年 | 72篇 |
2002年 | 63篇 |
2001年 | 26篇 |
2000年 | 23篇 |
1999年 | 38篇 |
1998年 | 44篇 |
1997年 | 27篇 |
1996年 | 32篇 |
1995年 | 26篇 |
1994年 | 22篇 |
1993年 | 21篇 |
1992年 | 15篇 |
1991年 | 17篇 |
1990年 | 12篇 |
1989年 | 16篇 |
1988年 | 12篇 |
1987年 | 11篇 |
1986年 | 14篇 |
1985年 | 9篇 |
1984年 | 6篇 |
1983年 | 8篇 |
1982年 | 6篇 |
1981年 | 6篇 |
1979年 | 9篇 |
1977年 | 6篇 |
1975年 | 8篇 |
1974年 | 14篇 |
1973年 | 7篇 |
1972年 | 6篇 |
1971年 | 10篇 |
排序方式: 共有1993条查询结果,搜索用时 46 毫秒
101.
Honorati Masanja Joanna Armstrong Schellenberg Hassan M Mshinda Meera Shekar Joseph KL Mugyabuso Godwin D Ndossi Don de Savigny 《BMC health services research》2006,6(1):142
Background
Efficient delivery strategies for health interventions are essential for high and sustainable coverage. We report impact of a change in programmatic delivery strategy from routine delivery through the Expanded Programme on Immunization (EPI+) approach to twice-yearly mass distribution campaigns on coverage of vitamin A supplementation in Tanzania 相似文献102.
Chemokine response in children with SARS. 总被引:2,自引:0,他引:2
P C Ng C W K Lam A M Li C K Wong T F Leung F W T Cheng K L E Hon I H S Chan E Wong T F Fok 《Archives of disease in childhood》2005,90(4):422-423
The chemokine response of eight children with serologically confirmed severe acute respiratory syndrome (SARS) was longitudinally monitored. All had raised plasma interferon gamma inducible protein (IP-10) concentrations, which suggested an active type 1 T-helper lymphocyte mediated immune response. High circulating IP-10 levels could facilitate viral clearance and might play a role in assisting the recovery of the patients. 相似文献
103.
104.
105.
NRM Buist AP Prince KL Huntington JM Tuerck DD Waggoner 《Acta paediatrica (Oslo, Norway : 1992)》1994,83(S407):75-77
A new amino acid mixture for incorporation into medical foods for the treatment of hyperphenylalaninemia has been tested in a regular clinic. The mix is designed to be as unobtrusive as possible, consistent with good nutrition. After more than 1 year of trial as a beverage, we have shown that it is safe and well tolerated but that plasma phenylalanine is no better controlled than with some other products. The mix can be incorporated into a large number of different foods without affecting the taste. Occult monitoring of the quantity of medical foods purchased compared with the amounts reported to be consumed in diet histories provides an excellent way to monitor dietary compliance. 相似文献
106.
107.
BACKGROUND: Second-line chemotherapy for patients with nonsmall cell lung carcinoma has been ineffective due to the lack of activity of older agents following platinum-based therapy. This Phase II trial evaluated the feasibility, toxicity, and efficacy of two active new agents, gemcitabine and vinorelbine, used in combination as second-line therapy for patients with nonsmall cell lung carcinoma. METHODS: Patients with advanced nonsmall cell lung carcinoma who had progressive disease after previous chemotherapy or combined-modality therapy were eligible for this trial. All patients received vinorelbine 20 mg/m(2) followed by gemcitabine 1000 mg/m(2) on Days 1, 8, and 15 of each 28-day cycle. Patients were reevaluated for a response after two treatment courses: responding patients and those with stable disease received a maximum of six courses. Fifty-five patients were treated between January 1998 and November 1998; 47 patients (85%) had previously received both a taxane and a platinum agent. RESULTS: Objective responses were seen in 9 of 50 evaluable patients (18%), including 8 partial responses and 1 complete response. Twenty-four additional patients (48%) had either minor response or stable disease. The median time to progression for patients with objective response or stable disease was 5 months. The median survival was 6.5 months with an actuarial 1-year survival of 20%. The treatment was well tolerated with uncommon nonhematologic toxicity and no alopecia. Grade 3 neutropenia and thrombocytopenia occurred in 27% and 22% of patients, respectively, but Grade 4 neutropenia was uncommon (occurring in 9% of patients) and only 4 patients required hospitalization for treatment of neutropenia and fever. CONCLUSIONS: The combination of vinorelbine and gemcitabine is active and well tolerated as second-line therapy for patients with advanced nonsmall cell lung carcinoma. This regimen merits further evaluation as a first-line therapy for patients with this disease. 相似文献
108.
109.
110.
THE GAUZE-HAMMOCK OPERATION 总被引:1,自引:0,他引:1